1033391-32-0Relevant articles and documents
A series of potent and selective, triazolylphenyl-based histone deacetylases inhibitors with activity against pancreatic cancer cells and Plasmodium falciparum
Chen, Yufeng,Lopez-Sanchez, Miriam,Savoy, Doris N.,Billadeau, Daniel D.,Dow, Geoffrey S.,Kozikowski, Alan P.
experimental part, p. 3437 - 3448 (2009/04/07)
The discovery of the rules governing the inhibition of the various HDAC isoforms is likely to be key to identifying improved therapeutics that act as epigenetic modulators of gene transcription. Herein we present results on the modification of the CAP reg